Product details
- ISBN 9781119847250
- Weight: 454g
- Dimensions: 10 x 10mm
- Publication Date: 17 Nov 2022
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
- Language: English
Secure
checkout
Fast Shipping
Easy returns
The latest entry in the widely read Drug Synthesis series
In Current Drug Synthesis, accomplished medicinal chemist and researcher Dr. Jie Jack Li and 27 expert coauthors deliver an authoritative and comprehensive discussion of the medicinal chemistry of current drugs, as well as the cutting-edge science involved in their synthesis. The book demystifies the process of modern drug discovery for both industry practitioners and students, while capturing the state-of-the-art techniques used to discover some of the most impactful medicines on the market today.
Covering six different disease areas – including infectious disease, cancer, cardiovascular and metabolic disease, the central nervous system, anti-inflammatory disease, and a miscellaneous section – the book explores 18 different drugs before concluding with chapters on computational drug discovery and peptide drugs.
Each chapter includes coverage of background material on a relevant drug class or disease indication and key aspects of drug discovery, including structure-activity relationships, pharmacokinetics, drug metabolism, efficacy, and safety.
Readers will also find:
- Thorough introductions to drugs for infectious diseases, including relebactam, vaborbactam, and baloxavir marboxil
- In-depth treatments of cancer-treating drugs, including darolutamide, venetoclax, and osimertinib
- Comprehensive explorations of central nervous system drugs, including zuranolone and risdiplam
- Extensive discussions of computational drug discovery and peptide drugs
Perfect for medicinal, organic, synthetic, and process chemists, Current Drug Synthesis will also earn a place in the libraries of research scientists working in lead optimization and process development, as well as graduate students studying organic chemistry, heterocyclic chemistry, or medicinal chemistry.
Jie Jack Li, PhD, is the CSO of GenHouse Bio. Previously, he was VP of Discovery Chemistry at ChemPartner, an Associate Professor of Chemistry at the University of San Francisco and a Medicinal Chemist at Pfizer and Bristol-Myers Squibb. He has authored or edited over 30 books, including Medicinal Chemistry for Practitioners published by Wiley in 2020.
